Amundi Pivots Away From Tech-Heavy Benchmarks, Betting On Commodities And Emerging Markets

Amundi Chief Investment Officer Vincent Mortier announced that the firm will adjust its 2027 portfolio, underweighting tech and shifting toward commodities, gold, emerging‑market and value equities, moving away from traditional cap‑weighted indexes as it questions the future profitability of AI‑driven tech companies.

Flagship Pioneering to establish first major UK biotech hub with £600 million investment plan

Flagship Pioneering founder Noubar Afeyan said the firm aims to raise as much as £600 million for its new UK investment, creating a full‑scale biotech company‑creation platform that will use AI to accelerate drug discovery. The move marks Flagship’s first major operation outside the US and highlights the need for regulatory safeguards around autonomous AI in biotech.

MARKETS
Loading market data...